- Home
- PDC vs OSRH Comparison
PDC vs OSRH Comparison
Compare PDC & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PDC | OSRH |
|---|---|---|
| Founded | 2018 | N/A |
| Country | Japan | United States |
| Employees | 20 | 21 |
| Industry | EDP Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.9M | 11.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PDC | OSRH |
|---|---|---|
| Price | $5.13 | $0.52 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 34.9K | ★ 785.7K |
| Earning Date | 07-01-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.46 | $0.38 |
| 52 Week High | $7.80 | $1.79 |
Technical Indicators
Market Signals| Indicator | PDC | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 49.53 | 53.72 |
| Support Level | $4.48 | $0.41 |
| Resistance Level | $5.50 | $0.60 |
| Average True Range (ATR) | 0.46 | 0.07 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 77.03 | 52.31 |
Price Performance
Historical ComparisonAbout PDC Perpetuals.com Ltd American Depositary Shares
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.